Signalling pathways evoked by α1-adrenoceptors in human melanoma cells

Cell Biochemistry and Function

Volumn 24, Issue 2, 2006, Pages 119-129

  Scarparo, Ana Cristina ^a   Visconti, Maria Aparecida ^a   De Lauro Castrucci, Ana Maria ^a,b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

1 adrenoceptors; Catecholamines; Cell proliferation; Human melanoma cells; Signalling pathways; Tyrosinase activity

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; BENOXATHIAN; CALCIUM; CATECHOLAMINE; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE; MONOPHENOL MONOOXYGENASE; PHENYLEPHRINE; PHOSPHATIDYLINOSITOL 3 KINASE; PIGMENT; PROTEIN KINASE C; SYNAPTOPHYSIN;

ARTICLE; CALCIUM TRANSPORT; CELL PROLIFERATION; CELL TRANSPORT; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; ENZYME IMMUNOASSAY; GRANULE CELL; HUMAN; HUMAN CELL; MELANOMA; PATHOGENESIS; PIGMENT CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; VERTEBRATE;

ADENINE; CELL LINE, TUMOR; CELL PROLIFERATION; CHROMONES; CYCLIC AMP; FORSKOLIN; HUMANS; IMIDAZOLES; INDOLES; ISOQUINOLINES; MELANOMA; MICROSCOPY, CONFOCAL; MONOPHENOL MONOOXYGENASE; MORPHOLINES; OXATHIINS; PHENYLEPHRINE; PYRIDINES; RECEPTORS, ADRENERGIC, ALPHA-1; SIGNAL TRANSDUCTION; SULFONAMIDES; THAPSIGARGIN;

MAMMALIA; VERTEBRATA;

EID: 33645281462     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.1309     Document Type: Article

References (71)

1. +2. Pharmacol Rev 1988; 40: 87-119.
2. 2-adrenergic receptors: comparison of pharmacologically defined subtypes with subtypes identified by molecular cloning. Mol Pharmacol 1992; 42: 1-5.
3. Bylund DB, Eikenberg DC, Hieble JP, et al. IV International Union of Pharmacology Nomenclature of Adrenoceptors. Pharmacol Rev 1994; 46: 121-136.
4. 2+ influx. Mol Pharmacol 1989; 36: 166-176.
5. Wilson KM, Minneman KP. Different pathways of [H-3] inositol phosphate formation mediated by alpha-1A-adrenergic and alpha-1B-adrenergic receptors. J Biol Chem 1990; 265: 17601-17606.
6. Jakobs HK, Saur W, Schultz G. Reduction of adenylate cyclase activity in lysates of human platelets by α-adrenergic component of epinephrine. J Cyclic Nucleotide Res 1976; 2: 381-392.
7. Collins S, Bolanowski MA, Caron MG, Lefkowitz RJ. Genetic regulation of β-adrenergic receptors. Annu Rev Physiol 1989; 51: 203-215.
8. 1-adrenergic receptor subtypes. Annu Rev Pharmacol Toxicol 1994; 34: 117-133.
9. 1- adrenoceptor-induced translocation of protein kinase C. Pharmacol Res 1997; 36: 211-219.
10. s in the transfected hamster ovary cells. Mol Pharmacol 1995; 48: 392-400.
11. 1- adrenergic receptors. J Biol Chem 1998; 273: 30033-30038.
12. 1A Adrenergic receptor stimulation with phenylephrine promotes arachidonic acid release by activation of phospholipase in Rat-1 fibroblasts: inhibition by protein kinase A. J Pharmacol Exp Therap 1998; 284: 576-585.
13. 1-adrenoceptors and protein kinase C activation. Biochem J 2002; 364: 73-79.
14. + current via a cAMP/PKA-mediated pathway in the rat heart. Am J Physiol Cell Physiol 2005; 288: C577-C585.
15. Markou T, Hadzopoulou-Cladaras M, Lazou A. Phenylephrine induces activation of CREB in adult rat cardiac myocytes through MSK1 and PKA signaling pathways. J Mol Cell Cardiol 2004; 37: 1001-1011.
16. Pierce KL, Premont RT, Lefkowitz RJ. Seven-transmembrane receptors. Mol C Biol 2002; 3: 639-650.
17. Koshimizu TA, Tanoue A, Hirasawa A, Yamauchi J, Tsujimoto G. Recent adances in alpha1-adrenoceptor pharmacology. Pharmacol Ther 2003; 98: 235-244.
18. Hague C, Chen Z, Uberti M, Minneman KP. Alpha(1)-adrenergic receptor subtypes: non-identical triplets with different dancing partners. Life Sci 2003; 74: 411-418.
19. 2- and β-adrenergic receptors to mitogen-activated protein kinase pathways and differentiation in transfected PC12 cells. J Biol Chem 1998; 273: 24624-24632.
20. 1A adrenergic receptor activation of mitogen-activated protein kinase pathways in transfected PC12 cells. Mol Pharmacol 1999; 55: 296-303.
21. q-mediated mitogen-activated protein kinase activation. J Biol Chem 1995; 270: 17148-17153.
22. 1A-adrenoceptors expressed in Rat-1 cells. Biochem Biophys Res Commun 1999; 261: 372-376.
23. 1A-adrenoceptors in Rat-1 cells inhibits extracellular signal-regulated kinase by activating p38 mitogen-activated protein kinase. Mol Pharmacol 1998; 54: 755-760.
24. Spector MS, Auer KL, Jarvis WD, et al. Differential regulation of the mitogen-activated protein and stress-activated protein kinase cascades by adrenergic agonists in quiescent and regenerating adult rat hepatocytes. Mol Cell Biol 1997; 17: 3556-3565.
25. 1D-adrenergic receptors and mitogen-activated protein kinase mediate increased protein synthesis by arterial smooth muscle. Mol Pharmacol 1997; 51: 764-775.
26. Zechner D, Thuerauf DJ, Hanford DS, McDonough PM, Glembotski CC. A role for the p38 mitogen-activated protein kinase pathway in myocardial cell growth, sarcomeric organization, and cardiac-specific gene expression. J Cell Biol 1997; 139: 115-127.
27. 1 adrenergic receptors activate phosphatidylinositol 3-kinase in human vascular smooth muscle cells. Role in mitogenesis. J Biol Chem 1996; 271: 8977-8982.
28. Cip1/WAF1-dependent pathway. FEBS Letters 1998; 436: 131-138.
29. 1- adrenoceptor subtypes differentially couple to growth promotion and inhibition in chinese hamster ovary cells. Biochem Biophys Res Commun 2000; 272: 906-911.
30. q-induced inhibition of cell proliferation. Biochem Biophys Res Commun 2001; 281: 1019-1023.
31. 1-adrenoceptor signal transduction system on human melanocytes. Exp Dermatol 1996; 5: 20-23.
32. Zhao H, Li L, Boissy RE, Nordlund JJ. Effects of autonomic neurotransmitters on human epidermal and ocular melanocytes in culture. XVIth International Pigment Cell Conference (Abs.) 1996, p. 85.
33. Fuller BB, Drake MA, Spaulding DT, Chaudhry F. Down-regulation of tyrosinase activity in human melanocyte cell cultures by yohimbine. J Invest Dermatol 2000; 114: 268-276.
34. Tsuji M, Kuno T, Tanaka C, Ichihashi M, Mishima Y. β-adrenergic receptors of B16 melanoma cell. Arch Dermatol Res 1983; 275: 415-416.
35. 2-adrenoceptors of cultured melanoma cells. Br J Dermato 1990; 123: 163-170.
36. Schallreuter KU, Wood JM, Ehrke C, Lemke R. Calcium transport and regulation in human primary and metastatic melanoma. Biochem Biophys Acta 1992a; 1160: 127-133.
37. Fitzpatrick TB, Eisen AZ, Wolff K, Freedberg IM, Austen KF. Dermatology in General Medicine (3rd edn). McGraw-Hill: New York, 1987.
38. Schallreuter KU, Wood JM, Lemke R, et al. Production of catecholamines in the human epidermis. Biochem Biophys Res Commun 1992b; 189: 72-78.
39. Scarparo AC, Visconti MA, Oliveira AR, Castrucci AML. Adrenoceptors in normal and malignant human melanocytes. Arch Dermatol Res 2000; 292: 265-267.
40. 1-adrenoceptors. Arch Dermatol Res 2004; 296: 112-119.
41. Maxwell LC, Herlihy JT, Riedel JL. Effects of ascorbic acid and EDTA on vascular concentration-response to catecholamines. Microvasc Res 1983; 26: 81-88.
42. Hugh D, Grennan A, Abugila MA, Weinkove C. Ascorbic acid as an antioxidant in measurements of catecholamines in plasma. Clin Chem 1987; 33: 569-571.
43. Neal MJ, Cunningham JR, Mattheus KL. Release of endogenous ascorbic acid preserves extracellular dopamine in the mammalian retina. Invest Ophthalmol Vis Sci 1999; 40: 2983-2987.
44. Pomerantz SH. The tyrosine hydroxylase activity of mammalian tyrosinase. J Biol Chem 1966; 241: 161-168.
45. Mengeaud V, Ortonne JP. Regulation of melanogenesis induced by 5-methoxypsoralen without UV light in murine melanoma cells. Pigment Cell Res 1994; 7: 245-254.
46. Dolmetsch RE, Xu K, Lewis RS. Calcium oscillations increase the efficiency and specificity of gene expression. Nature 1998; 392: 933-936.
47. 2+ spike frequency can optimize gene expression. Nature 1998; 392: 936-941.
48. 2+ signaling in non-excitable cells. Cell Calcium 2003; 34: 431-444.
49. deOliveira AR, Castrucci AML, Visconti MA. Cellular signaling in vertebrate pigment cells. Braz J Med Biol Res 1996; 29: 1743-1749.
50. Bertollotto C, Buscà R, Abbe P, et al. Different cis-acting elements are involved in the regulation of TRP1 and TRP2 promotor activities by cyclic AMP: pivotal role of M boxes (GTCATGTGCT) and of microphtalmia. Mol Cell Biol 1998; 18: 694-702.
51. Park H-Y, Gilchrest B. Signaling pathways mediating melanogenesis. Cell Mol Biol 1999; 45: 919-930.
52. Buscà R, Ballotti R. Cyclic AMP: a key messenger in the regulation of skin pigmentation. Pigment Cell Res 2000; 13: 60-69.
53. Halaban R. The regulation of normal melanocyte proliferation. Pigment Cell Res 2000; 13: 4-14.
54. Jiang J, Sharma SD, Nakamura S, et al. The melanotropic peptide, [Nle4, D-Phe7]α-MSH, stimulates human melanoma tyrosinase activity and inhibits cell proliferation. Pigment Cell Res 1995; 8: 314-323.
55. Gordon PR, Gilchrest BA. Human melanogenesis is stimulated by diacylglycerol. J Invest Dermatol 1989; 93: 700-702.
56. Park H-Y, Russakovsky V, Ohno S, Gilchrest BA. The β isoform of protein kinase C stimulates human melanogenesis by activating tyrosinase in pigment cells. J Biol Chem 1993; 268: 11742-11749.
57. Park H-Y, Perez JM, Laursen R, Hara M, Gilchrest BA. Protein kinase C-β activates tyrosinase by phosphorylating serine residues in its cytoplasmatic domain. J Cell Biol 1999; 274: 16470-16478.
58. Park H-Y. Regulation of human melanogenesis by protein kinase C-β. Pigment Cell Res 2000; 13: 197.
59. Gilhooly EM, Morse-Gaudio M, Bianchi L, et al. Loss of expression of protein kinase C beta is a common phenomenon in human malignant melanoma: a result of transformation or differentiation? Melanoma Res 2001; 11: 355-369.
60. Yamanishi DT, Graham M, Buckmeier JA, Meyskens FL Jr. The differential expression of protein kinase C genes in normal human neonatal melanocytes and metastatic melanomas. Carcinogenesis 1991; 12: 105-109.
61. Yamanishi DT, Meyskens FL Jr. Alterations in gene expression and signal transductions in human melanocytes and melanoma cells. Crit Rev Oncog 1994; 5: 429-450.
62. Krasagakis K, Fimmel S, Genten D, et al. Lack of protein kinase C (PKC)-beta and low PKC-alpha, -delta, -epsilon, and -zeta isozyme levels in proliferation human melanoma cells. Int J Oncol 2002; 20: 865-871.
63. Selzer E, Okamoto I, Kodyn R, Pehamberger H, Jansen B. Protein kinase C isoforms in normal and transformed cells of the melanocytic lineage. Melanoma Res 2002; 12: 201-209.
64. Richards J. New signaling pathways for hormones and cyclic adenosine 3′,5′-monophosphate action in endocrine cells. Mol Endocrinol 2001; 15: 209-218.
65. Buscà R, Bertollotto C, Ortonne J-P, Ballotti R. Inhibition of the phosphatidylinositol 3-kinase/p70S6-kinase pathway induces B16 melanoma cell differentiation. J Biol Chem 1996; 271: 31824-31830.
66. Galibert MD, Carreira S, Goding CR. The Usf-1 transcription factor is a novel target for the stress-responsive p38 kinase and mediates UV-induced tyrosinase expression. EMBO J 2001; 20: 5022-5031.
67. Tada A, Pereira E, Beitner-Johnson D, Kavanagh R, Abdel-Malek ZA. Mitogen- and ultraviolet-B-induced signaling pathways in normal human melanocytes. J Invest Dermatol 2002; 118: 316-322.
68. Englaro W, Rezzonico R, Durand-Clement M, Lallemand D, Ortonne J-P, Ballotti R. Mitogen-activated protein kinase pathway and AP-1 are activated during cAMP-induced melanogenesis in B16 melanoma cells. J Biol Chem 1995; 270: 24315-24320.
69. th International Pigment Cell Conference (Suppl. 7): 73.
70. th International Pigment Cell Conference (Suppl. 7): 31-32.
71. Stork PJS, Schmitt JM. Crosstalk between cAMP and MAP Kinase signaling in the regulation of the cell proliferation. Trends Cell Biol 2002; 12: 258-266.